Loading organizations...
Loading organizations...
Learn which startups K50 Ventures invests in, what size check sizes they write, and who their partners are (e.g. Ryan Bloomer).
Key people at K50 Ventures.
"K50 Ventures is an early investor and supporter of 140+ mission-driven companies across the US and Emerging Markets. Our thesis is simple, improve the lives of billions around the world by making health, education, finance, and housing more affordable, accessible, and sustainable. Some highlights of the portfolio include Self, Mammoth Biosciences,Frubana, Groww, Real, Narmi, Shef, Easyknock, and more."
K50 Ventures is a purpose-driven, early-stage venture capital firm that backs mission-oriented founders building technology to unlock access and affordability for the global working class. The firm’s core thesis centers on improving daily life across three foundational domains: health, finance, and work. While education and housing are sometimes referenced in broader impact narratives, K50’s primary investment focus is on healthtech, fintech, and future-of-work innovations that directly serve underserved populations.
K50 positions itself as the first institutional check for founders, typically investing at the pre-seed and seed stages with check sizes ranging from $100K to $3M. It has deployed capital into more than 150 companies globally, with a portfolio that includes high-impact startups like Mammoth Biosciences (CRISPR-based diagnostics), Groww (India’s mobile-first investing platform), and Midi Health (women’s health for those over 40). The firm emphasizes both strong financial returns and measurable social impact, aiming to support companies that generate top-decile venture performance while materially improving outcomes for millions of people and small businesses.
K50 Ventures traces its roots to the Kairos Society, a global community of student entrepreneurs, and its annual “K50” program that identified the top 50 purpose-driven startups worldwide. From this foundation, K50 evolved into an independent venture firm in 2016–2017, formalizing its focus on early-stage, mission-driven companies. Headquartered in New York, the firm was co-founded and is led by Ryan Bloomer and Adriel Bercow, who brought together a team with deep experience across startups, scaling operations, and venture investing.
The firm’s early years were defined by a deliberate shift from a broad “purpose-driven” mandate to a sharper focus on the working class and the systems that constrain their economic and health outcomes. This crystallized into a concentrated thesis around health, finance, and work—sectors where technology could dramatically lower barriers to access and affordability. Over time, K50 built a reputation for being founder-friendly, hands-on, and globally minded, with investments spanning the U.S., Latin America, India, Africa, and parts of Asia-Pacific.
K50 is not a generalist early-stage fund. It deliberately targets startups that aim to democratize access in health, finance, and work, especially for the global working class. This focus allows the team to develop deep domain expertise and build a concentrated, high-conviction portfolio.
K50 often writes the first institutional check for founders, typically at pre-seed or seed stage. But it also positions itself as a long-term partner, staying engaged through subsequent rounds and scaling phases. This dual role—early believer and enduring supporter—resonates with founders building capital-intensive, impact-oriented businesses.
The team combines venture experience (with exposure to 300+ startups and 30+ funds) with real-world operating backgrounds at companies like Amazon, Uber, Rappi, Brex, and Ro. This operational fluency, combined with a network of 10+ venture partners, 100+ LPs, and 350+ founders, enables K50 to add meaningful value in sourcing, diligence, and scaling.
While based in New York, K50 actively invests in high-growth emerging markets, particularly in Latin America and India. Its portfolio includes companies like Groww (India) and fintechs serving Mexican consumers, reflecting a strong conviction in the potential of tech to leapfrog legacy systems in these regions.
Unlike funds that treat impact as a separate vertical, K50 embeds it into its core investment criteria. The firm looks for founders who are dissatisfied with the status quo and have a clear vision for improving lives at scale—whether by expanding access to credit, reimagining care for women over 40, or empowering small businesses and independent workers.
K50 Ventures is riding a powerful convergence of trends: the rise of fintech and healthtech in emerging markets, the growing demand for equitable work models, and the increasing expectation that technology should serve more than just the affluent. As legacy systems in healthcare, finance, and labor markets struggle with inefficiency and exclusion, K50 is backing startups that use software to create more accessible, affordable, and user-centric alternatives.
The firm’s focus on the “99%” aligns with a broader shift in venture capital toward inclusive innovation—where returns are tied not just to market size, but to how many people a company can uplift. In health, this means backing CRISPR-based diagnostics and women’s health platforms that reach underserved populations. In finance, it means mobile-first investing, credit-building tools, and embedded financial services for the unbanked and underbanked. In work, it means tools for small businesses, creators, and independent workers who are often overlooked by traditional enterprise software.
K50’s global lens is particularly relevant in a world where innovation is increasingly decentralized. By investing in Latin America, India, and Africa, the firm is helping to amplify local solutions to local problems, while also proving that purpose-driven companies can achieve venture-scale outcomes. In doing so, K50 is shaping a new archetype of the early-stage VC: one that is deeply sector-focused, globally distributed, and equally committed to returns and impact.
K50 Ventures is well-positioned to deepen its influence as the next wave of inclusive tech matures. As more founders build for the working class—not just in the U.S. but across emerging markets—K50’s focused thesis, global reach, and operator-led support will remain a compelling advantage. The firm is likely to continue expanding its footprint in high-growth regions, while also doubling down on its core sectors as they evolve (e.g., mental health, women’s health, embedded finance, and tools for the future of work).
Looking ahead, K50 may raise additional funds to increase check sizes and extend its ownership in later-stage rounds, while maintaining its early-stage identity. It could also play a more active role in shaping policy and ecosystem conversations around inclusive innovation, especially as regulators and institutions pay more attention to equitable access in health and finance.
Ultimately, K50’s bet is that the most durable, high-impact companies of the next decade will be those that solve real, everyday problems for the majority of people—not just the privileged few. If that vision holds, K50 won’t just be a successful VC firm; it will be a defining force in building a more equitable tech economy.
Key people at K50 Ventures.
